English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Os autores estudaram 31 pacientes portadores de tinhas crural, do corpo e do pé interdigital, tratados com 100 mg de itraconazol, administrados junto com o almoço, durante 15 dias. Foram realizadas 3 avaliações clínicas e micológicas: no pré-tratamento, no final do tratamento e 2 semanas após o tratamento. O itraconazol mostrou-se eficaz para o tratamento das dermatofitoses estudadas, na dose empregada, com 100% de cura micológica. Em relação a evolução clínica, houve diminuição estatística significante (teste de Friedman - p < 0,001) dos sinais e sintomas avaliados. Não foi observada ocorrência de efeitos colaterais. The authors studied 31 patients with Tinea cruris, corporis or pedis interdigital. The patients were treated with 100 mg of itraconazole, once a day, during the lunch, for 15 days. Mycological and clinical evaluations were performed at the pre-treatment, by the end of treatment and 2 weeks after finishing the treatment. The results showed that itraconazole is effective for the treatment of dermatophytosis, at the studied posology. with 100% of mycological cure. Clinical evaluation showed a significant reduction (Friedman test - p < 0.001) of signs and symptoms. No side-effect was registered

Estudo clínico com o uso do itraconazol em tinha crural, tinha do corpo e tinha do pé interdigital